Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

New View Surgical

Request full access

Focused on improving the outcomes of laparoscopic surgical procedures

Boston, United StatesFounded 2009Health Tech & Medtech

About New View Surgical

New View Surgical, Inc. operates within the minimally invasive surgery (MIS) sector, focusing on the commercialization of advanced visualization technologies. Founded in December 2009 by Art McKinley, Jesse Plouffe, and Bryce Klontz, the Boston-based company aims to enhance the outcomes of laparoscopic surgical procedures. The firm's direction is significantly shaped by the extensive experience of its leadership. Bryce Klontz, the former President and CEO, brought over two decades of medtech experience, including a tenure as Vice President of Commercial Strategy and Emerging Markets at Covidien, where he was instrumental in expanding into new global markets. This background in global commercial strategy is pivotal to New View Surgical's mission.

The company's core offering is the VisionPort™ System, a surgical imaging and access platform. This system consolidates four separate pieces of surgical equipment—the laparoscope, camera, light source, and access port—into a single, disposable device. This integration is designed to streamline surgical workflows by giving the surgeon direct control over visualization, which traditionally requires a dedicated assistant. A key feature of the VisionPort is its dual-camera design, which provides multiple, simultaneous views of the surgical field, a capability not available with conventional laparoscopes. By eliminating the need for a separate camera port, the system can reduce the number of incisions required for a procedure. The first-in-human use of the VisionPort System was for a laparoscopic cholecystectomy (gallbladder removal) in December 2022.

New View Surgical's business model centers on the sale of its disposable VisionPort System to hospitals and surgical centers. The company targets a broad range of diagnostic and therapeutic procedures within the thoracic and abdominal cavities. A significant part of its value proposition is the potential for cost savings for healthcare facilities by reducing the need for capital-intensive equipment and potentially decreasing case times and staffing requirements. The company has successfully navigated the regulatory landscape, receiving 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VisionPort System in June 2021. To finance its operations, development, and commercialization efforts, New View Surgical has raised a total of $26.8 million through several funding rounds, including a $12.1 million Series B round in September 2022, with investments from groups like New York Angels, Mid Atlantic Bio Angels, and Keiretsu Forum.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2009
Headquarters
Boston, United States
Employees
3
Open positions
None listed
Dealroom signal
65.1/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Surgery, Medical Imaging, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Oct 2022 $12M $48M Undisclosed ↗
OtherOther financing Jun 2022 $0 — MedTech Innovator ↗
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

New View Surgical website traffic

Latest recorded traffic for New View Surgical is 1.9K monthly website visits, up 295.8% over the last three months. New View Surgical's team grew 0% over the past year.

Latest monthly visits1.9K 3-month web change+295.8% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

New View Surgical in the Boston ecosystem

Live from Dealroom

The New View Surgical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • MassChallenge
  • Keiretsu Forum

Series A7 investors entered at this stage

  • New York Angels
  • Mid Atlantic Bio Angels
  • Ariel Savannah Angel Partners
  • IAG Capital Partners
  • Charleston Angel Partners
  • Corza Medical
  • SSIP

Other known investors5 additional known investors

  • MedTech Innovator
  • Ariel Southeast Angel Partners
  • KYTO Technology & Life Science
  • Sacha Levy
  • Tech Coast Angels
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about New View Surgical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See New View Surgical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.